Xarelto is marketed as an anticoagulant prescribed to reduce the risk of stroke, deep-vein thrombosis and pulmonary embolism. It is manufactured in the United States by Bayer and Johnson & Johnson’s New Jersey-based division, Janssen Pharmaceuticals. Lawsuits have been filed nationwide based on claims that Xarelto is responsible for injuries in some individuals.
Lawsuits allege that Xarelto was marketed as safer than warfarin, another anticoagulant, but recent studies, including from the Canadian Journal of Cardiology (December 2014 – Volume 30, Issue 12), suggest otherwise. The study allegedly found that the safety profiles of the drugs were nearly identical when it came to bleeding risks and other side effects common to blood thinners used to treat patients with atrial fibrillation.
If you feel you have experienced any side-effects from taking Xarelto, you can contact Stark & Stark and speak to one of the Mass Tort/Pharmaceutical Litigation attorneys, free of charge, who can help assess any claims that you might have against the Xarelto manufacturers.